nodes	percent_of_prediction	percent_of_DWPC	metapath
Megestrol acetate—PGR—multiple sclerosis	0.222	1	CbGaD
Megestrol acetate—breast cancer—Betamethasone—multiple sclerosis	0.132	0.5	CpDpCtD
Megestrol acetate—breast cancer—Dexamethasone—multiple sclerosis	0.132	0.5	CpDpCtD
Megestrol acetate—PGR—Betamethasone—multiple sclerosis	0.0444	0.181	CbGbCtD
Megestrol acetate—NR3C1—Methylprednisolone—multiple sclerosis	0.0349	0.142	CbGbCtD
Megestrol acetate—NR3C1—Triamcinolone—multiple sclerosis	0.0265	0.107	CbGbCtD
Megestrol acetate—PGR—Dexamethasone—multiple sclerosis	0.0258	0.105	CbGbCtD
Megestrol acetate—NR3C1—Betamethasone—multiple sclerosis	0.0227	0.0922	CbGbCtD
Megestrol acetate—NR3C1—Prednisolone—multiple sclerosis	0.0224	0.091	CbGbCtD
Megestrol acetate—NR3C1—Prednisone—multiple sclerosis	0.0211	0.0859	CbGbCtD
Megestrol acetate—NR3C1—Dexamethasone—multiple sclerosis	0.0132	0.0536	CbGbCtD
Megestrol acetate—Potassium Canrenoate—Prednisone—multiple sclerosis	0.00914	0.035	CrCrCtD
Megestrol acetate—Potassium Canrenoate—Prednisolone—multiple sclerosis	0.00892	0.0341	CrCrCtD
Megestrol acetate—Medrysone—Methylprednisolone—multiple sclerosis	0.00846	0.0324	CrCrCtD
Megestrol acetate—Medroxyprogesterone Acetate—Methylprednisolone—multiple sclerosis	0.00815	0.0312	CrCrCtD
Megestrol acetate—ABCB1—Methylprednisolone—multiple sclerosis	0.00813	0.033	CbGbCtD
Megestrol acetate—Medrysone—Prednisolone—multiple sclerosis	0.00754	0.0288	CrCrCtD
Megestrol acetate—Hydrocortamate—Methylprednisolone—multiple sclerosis	0.00736	0.0281	CrCrCtD
Megestrol acetate—Difluprednate—Methylprednisolone—multiple sclerosis	0.00736	0.0281	CrCrCtD
Megestrol acetate—Difluprednate—Dexamethasone—multiple sclerosis	0.00724	0.0277	CrCrCtD
Megestrol acetate—Difluprednate—Betamethasone—multiple sclerosis	0.00724	0.0277	CrCrCtD
Megestrol acetate—Cortisone acetate—Methylprednisolone—multiple sclerosis	0.00713	0.0273	CrCrCtD
Megestrol acetate—Difluprednate—Triamcinolone—multiple sclerosis	0.00708	0.0271	CrCrCtD
Megestrol acetate—Prednicarbate—Methylprednisolone—multiple sclerosis	0.00692	0.0265	CrCrCtD
Megestrol acetate—Prednicarbate—Dexamethasone—multiple sclerosis	0.00681	0.0261	CrCrCtD
Megestrol acetate—Prednicarbate—Betamethasone—multiple sclerosis	0.00681	0.0261	CrCrCtD
Megestrol acetate—Hydrocortamate—Prednisone—multiple sclerosis	0.00671	0.0257	CrCrCtD
Megestrol acetate—Prednicarbate—Triamcinolone—multiple sclerosis	0.00665	0.0255	CrCrCtD
Megestrol acetate—Hydrocortamate—Prednisolone—multiple sclerosis	0.00655	0.0251	CrCrCtD
Megestrol acetate—Cortisone acetate—Prednisone—multiple sclerosis	0.00651	0.0249	CrCrCtD
Megestrol acetate—Cortisone acetate—Prednisolone—multiple sclerosis	0.00635	0.0243	CrCrCtD
Megestrol acetate—Prednicarbate—Prednisone—multiple sclerosis	0.00631	0.0242	CrCrCtD
Megestrol acetate—Fluoxymesterone—Betamethasone—multiple sclerosis	0.00626	0.0239	CrCrCtD
Megestrol acetate—Fluoxymesterone—Dexamethasone—multiple sclerosis	0.00626	0.0239	CrCrCtD
Megestrol acetate—Fludrocortisone—Methylprednisolone—multiple sclerosis	0.00619	0.0237	CrCrCtD
Megestrol acetate—Prednicarbate—Prednisolone—multiple sclerosis	0.00616	0.0236	CrCrCtD
Megestrol acetate—Fluoxymesterone—Triamcinolone—multiple sclerosis	0.00612	0.0234	CrCrCtD
Megestrol acetate—Fludrocortisone—Dexamethasone—multiple sclerosis	0.0061	0.0233	CrCrCtD
Megestrol acetate—Fludrocortisone—Betamethasone—multiple sclerosis	0.0061	0.0233	CrCrCtD
Megestrol acetate—Fludrocortisone—Triamcinolone—multiple sclerosis	0.00596	0.0228	CrCrCtD
Megestrol acetate—ABCB1—Mitoxantrone—multiple sclerosis	0.00593	0.0241	CbGbCtD
Megestrol acetate—Fluoxymesterone—Prednisolone—multiple sclerosis	0.00566	0.0217	CrCrCtD
Megestrol acetate—Fludrocortisone—Prednisone—multiple sclerosis	0.00565	0.0216	CrCrCtD
Megestrol acetate—Fludrocortisone—Prednisolone—multiple sclerosis	0.00552	0.0211	CrCrCtD
Megestrol acetate—Progesterone—Prednisolone—multiple sclerosis	0.00552	0.0211	CrCrCtD
Megestrol acetate—Methyltestosterone—Prednisone—multiple sclerosis	0.00551	0.0211	CrCrCtD
Megestrol acetate—Methyltestosterone—Prednisolone—multiple sclerosis	0.00538	0.0206	CrCrCtD
Megestrol acetate—ABCB1—Betamethasone—multiple sclerosis	0.00529	0.0215	CbGbCtD
Megestrol acetate—ABCB1—Prednisolone—multiple sclerosis	0.00521	0.0212	CbGbCtD
Megestrol acetate—Hydrocortisone—Methylprednisolone—multiple sclerosis	0.00505	0.0193	CrCrCtD
Megestrol acetate—Hydrocortisone—Betamethasone—multiple sclerosis	0.00497	0.019	CrCrCtD
Megestrol acetate—Hydrocortisone—Dexamethasone—multiple sclerosis	0.00497	0.019	CrCrCtD
Megestrol acetate—ABCB1—Prednisone—multiple sclerosis	0.00492	0.02	CbGbCtD
Megestrol acetate—Hydrocortisone—Triamcinolone—multiple sclerosis	0.00486	0.0186	CrCrCtD
Megestrol acetate—Testosterone—Prednisolone—multiple sclerosis	0.00479	0.0183	CrCrCtD
Megestrol acetate—Hydrocortisone—Prednisone—multiple sclerosis	0.00461	0.0176	CrCrCtD
Megestrol acetate—Hydrocortisone—Prednisolone—multiple sclerosis	0.0045	0.0172	CrCrCtD
Megestrol acetate—ABCB1—Dexamethasone—multiple sclerosis	0.00307	0.0125	CbGbCtD
Megestrol acetate—ABCB1—Methotrexate—multiple sclerosis	0.00247	0.01	CbGbCtD
Megestrol acetate—Dydrogesterone—PGR—multiple sclerosis	0.000404	0.264	CrCbGaD
Megestrol acetate—Ethynodiol—PGR—multiple sclerosis	0.000333	0.218	CrCbGaD
Megestrol acetate—Drospirenone—PGR—multiple sclerosis	0.000212	0.139	CrCbGaD
Megestrol acetate—NR3C1—Endoderm Differentiation—HHEX—multiple sclerosis	0.000204	0.0456	CbGpPWpGaD
Megestrol acetate—PGR—Cellular roles of Anthrax toxin—VCAM1—multiple sclerosis	0.000181	0.0404	CbGpPWpGaD
Megestrol acetate—Spironolactone—PGR—multiple sclerosis	0.000151	0.0989	CrCbGaD
Megestrol acetate—Drospirenone—BCHE—multiple sclerosis	0.000145	0.0951	CrCbGaD
Megestrol acetate—Medroxyprogesterone Acetate—PGR—multiple sclerosis	0.000142	0.0927	CrCbGaD
Megestrol acetate—NR3C1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000124	0.0276	CbGpPWpGaD
Megestrol acetate—PGR—Ovarian Infertility Genes—VDR—multiple sclerosis	0.000121	0.0271	CbGpPWpGaD
Megestrol acetate—NR3C1—Endoderm Differentiation—EOMES—multiple sclerosis	0.000117	0.0262	CbGpPWpGaD
Megestrol acetate—NR3C1—Endoderm Differentiation—TBX21—multiple sclerosis	0.000117	0.0262	CbGpPWpGaD
Megestrol acetate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00011	0.0245	CbGpPWpGaD
Megestrol acetate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00011	0.0245	CbGpPWpGaD
Megestrol acetate—PGR—Nuclear Receptors—VDR—multiple sclerosis	0.000106	0.0236	CbGpPWpGaD
Megestrol acetate—NR3C1—Glucocorticoid receptor regulatory network—TBX21—multiple sclerosis	0.000101	0.0226	CbGpPWpGaD
Megestrol acetate—NR3C1—Nuclear Receptors—PGR—multiple sclerosis	8.74e-05	0.0196	CbGpPWpGaD
Megestrol acetate—PGR—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	8.35e-05	0.0187	CbGpPWpGaD
Megestrol acetate—PGR—Cellular roles of Anthrax toxin—IL1B—multiple sclerosis	8.35e-05	0.0187	CbGpPWpGaD
Megestrol acetate—Progesterone—PGR—multiple sclerosis	8.17e-05	0.0535	CrCbGaD
Megestrol acetate—NR3C1—Endoderm Differentiation—PABPC1—multiple sclerosis	7.73e-05	0.0173	CbGpPWpGaD
Megestrol acetate—NR3C1—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	6.91e-05	0.0155	CbGpPWpGaD
Megestrol acetate—PGR—Generic Transcription Pathway—ZNF746—multiple sclerosis	6.84e-05	0.0153	CbGpPWpGaD
Megestrol acetate—PGR—Cellular roles of Anthrax toxin—MAPK1—multiple sclerosis	6.36e-05	0.0142	CbGpPWpGaD
Megestrol acetate—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	6.24e-05	0.014	CbGpPWpGaD
Megestrol acetate—NR3C1—Nuclear Receptors—VDR—multiple sclerosis	6.11e-05	0.0137	CbGpPWpGaD
Megestrol acetate—PGR—Cellular roles of Anthrax toxin—TNF—multiple sclerosis	6.06e-05	0.0136	CbGpPWpGaD
Megestrol acetate—NR3C1—Glucocorticoid receptor regulatory network—SELE—multiple sclerosis	5.8e-05	0.013	CbGpPWpGaD
Megestrol acetate—NR3C1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	5.13e-05	0.0115	CbGpPWpGaD
Megestrol acetate—PGR—Signaling by ERBB4—CD28—multiple sclerosis	4.85e-05	0.0108	CbGpPWpGaD
Megestrol acetate—NR3C1—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	4.83e-05	0.0108	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—C4A—multiple sclerosis	4.75e-05	0.0106	CbGpPWpGaD
Megestrol acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	4.2e-05	0.0094	CbGpPWpGaD
Megestrol acetate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—multiple sclerosis	4.14e-05	0.00925	CbGpPWpGaD
Megestrol acetate—NR3C1—Generic Transcription Pathway—ZNF746—multiple sclerosis	3.95e-05	0.00885	CbGpPWpGaD
Megestrol acetate—NR3C1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	3.89e-05	0.00869	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	3.87e-05	0.00866	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	3.87e-05	0.00866	CbGpPWpGaD
Megestrol acetate—Methyltestosterone—ALB—multiple sclerosis	3.74e-05	0.0245	CrCbGaD
Megestrol acetate—NR3C1—AP-1 transcription factor network—IL10—multiple sclerosis	3.64e-05	0.00815	CbGpPWpGaD
Megestrol acetate—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	3.59e-05	0.00802	CbGpPWpGaD
Megestrol acetate—NR3C1—AP-1 transcription factor network—IL4—multiple sclerosis	3.55e-05	0.00793	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	3.52e-05	0.00788	CbGpPWpGaD
Megestrol acetate—NR3C1—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	3.5e-05	0.00783	CbGpPWpGaD
Megestrol acetate—PGR—Signaling by ERBB4—CD86—multiple sclerosis	3.46e-05	0.00773	CbGpPWpGaD
Megestrol acetate—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	3.41e-05	0.00762	CbGpPWpGaD
Megestrol acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	3.33e-05	0.00746	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	3.32e-05	0.00743	CbGpPWpGaD
Megestrol acetate—PGR—Gene Expression—ZNF746—multiple sclerosis	3.29e-05	0.00737	CbGpPWpGaD
Megestrol acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	3.24e-05	0.00725	CbGpPWpGaD
Megestrol acetate—NR3C1—AP-1 transcription factor network—HLA-A—multiple sclerosis	3.21e-05	0.00718	CbGpPWpGaD
Megestrol acetate—NR3C1—Glucocorticoid receptor regulatory network—IL4—multiple sclerosis	3.12e-05	0.00699	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	3.02e-05	0.00675	CbGpPWpGaD
Megestrol acetate—PGR—Gene Expression—PTBP1—multiple sclerosis	3.01e-05	0.00674	CbGpPWpGaD
Megestrol acetate—NR3C1—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	2.83e-05	0.00632	CbGpPWpGaD
Megestrol acetate—PGR—Validated nuclear estrogen receptor alpha network—MYC—multiple sclerosis	2.77e-05	0.00619	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	2.61e-05	0.00585	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—CD28—multiple sclerosis	2.54e-05	0.00568	CbGpPWpGaD
Megestrol acetate—PGR—Signaling by ERBB4—CD80—multiple sclerosis	2.52e-05	0.00564	CbGpPWpGaD
Megestrol acetate—NR3C1—AP-1 transcription factor network—CCL2—multiple sclerosis	2.52e-05	0.00564	CbGpPWpGaD
Megestrol acetate—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	2.48e-05	0.00555	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	2.43e-05	0.00544	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	2.41e-05	0.00539	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—CD40—multiple sclerosis	2.32e-05	0.00519	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	2.29e-05	0.00511	CbGpPWpGaD
Megestrol acetate—PGR—Gene Expression—U2AF2—multiple sclerosis	2.28e-05	0.00511	CbGpPWpGaD
Megestrol acetate—PGR—Gene Expression—HNRNPA1—multiple sclerosis	2.28e-05	0.00511	CbGpPWpGaD
Megestrol acetate—NR3C1—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	2.27e-05	0.00508	CbGpPWpGaD
Megestrol acetate—Testosterone—ALB—multiple sclerosis	2.17e-05	0.0142	CrCbGaD
Megestrol acetate—NR3C1—AP-1 transcription factor network—IFNG—multiple sclerosis	2.14e-05	0.00479	CbGpPWpGaD
Megestrol acetate—PGR—Signaling by ERBB4—TYK2—multiple sclerosis	2.13e-05	0.00476	CbGpPWpGaD
Megestrol acetate—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	2.09e-05	0.00467	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	2.01e-05	0.0045	CbGpPWpGaD
Megestrol acetate—NR3C1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	2.01e-05	0.0045	CbGpPWpGaD
Megestrol acetate—NR3C1—Adipogenesis—FAS—multiple sclerosis	1.99e-05	0.00445	CbGpPWpGaD
Megestrol acetate—NR3C1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	1.92e-05	0.00429	CbGpPWpGaD
Megestrol acetate—NR3C1—AP-1 transcription factor network—IL2—multiple sclerosis	1.9e-05	0.00426	CbGpPWpGaD
Megestrol acetate—NR3C1—Gene Expression—ZNF746—multiple sclerosis	1.9e-05	0.00426	CbGpPWpGaD
Megestrol acetate—NR3C1—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	1.89e-05	0.00422	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	1.88e-05	0.00421	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—CD86—multiple sclerosis	1.81e-05	0.00405	CbGpPWpGaD
Megestrol acetate—PGR—Gene Expression—ZFP36L1—multiple sclerosis	1.8e-05	0.00404	CbGpPWpGaD
Megestrol acetate—NR3C1—AP-1 transcription factor network—MMP9—multiple sclerosis	1.8e-05	0.00403	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	1.78e-05	0.00398	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—IL10—multiple sclerosis	1.78e-05	0.00398	CbGpPWpGaD
Megestrol acetate—NR3C1—Gene Expression—PTBP1—multiple sclerosis	1.74e-05	0.0039	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—IL4—multiple sclerosis	1.73e-05	0.00387	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—LINGO1—multiple sclerosis	1.71e-05	0.00383	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	1.69e-05	0.00378	CbGpPWpGaD
Megestrol acetate—NR3C1—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	1.68e-05	0.00375	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—FAS—multiple sclerosis	1.59e-05	0.00356	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	1.58e-05	0.00354	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	1.57e-05	0.0035	CbGpPWpGaD
Megestrol acetate—NR3C1—Endoderm Differentiation—TGFB1—multiple sclerosis	1.52e-05	0.0034	CbGpPWpGaD
Megestrol acetate—NR3C1—AP-1 transcription factor network—MYC—multiple sclerosis	1.49e-05	0.00333	CbGpPWpGaD
Megestrol acetate—NR3C1—AP-1 transcription factor network—TGFB1—multiple sclerosis	1.49e-05	0.00332	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—TAGAP—multiple sclerosis	1.48e-05	0.00332	CbGpPWpGaD
Megestrol acetate—PGR—Generic Transcription Pathway—VDR—multiple sclerosis	1.44e-05	0.00323	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	1.43e-05	0.0032	CbGpPWpGaD
Megestrol acetate—PGR—Gene Expression—PABPC1—multiple sclerosis	1.4e-05	0.00313	CbGpPWpGaD
Megestrol acetate—PGR—Signaling by ERBB4—MAPK1—multiple sclerosis	1.36e-05	0.00303	CbGpPWpGaD
Megestrol acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	1.33e-05	0.00296	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—CD80—multiple sclerosis	1.32e-05	0.00296	CbGpPWpGaD
Megestrol acetate—NR3C1—Gene Expression—U2AF2—multiple sclerosis	1.32e-05	0.00295	CbGpPWpGaD
Megestrol acetate—NR3C1—Gene Expression—HNRNPA1—multiple sclerosis	1.32e-05	0.00295	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—S1PR1—multiple sclerosis	1.3e-05	0.0029	CbGpPWpGaD
Megestrol acetate—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	1.28e-05	0.00287	CbGpPWpGaD
Megestrol acetate—PGR—Gene Expression—RPL5—multiple sclerosis	1.26e-05	0.00282	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—GPC5—multiple sclerosis	1.26e-05	0.00282	CbGpPWpGaD
Megestrol acetate—NR3C1—Generic Transcription Pathway—PGR—multiple sclerosis	1.19e-05	0.00267	CbGpPWpGaD
Megestrol acetate—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.18e-05	0.00263	CbGpPWpGaD
Megestrol acetate—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	1.14e-05	0.00256	CbGpPWpGaD
Megestrol acetate—NR3C1—AP-1 transcription factor network—IL6—multiple sclerosis	1.12e-05	0.0025	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—RGS1—multiple sclerosis	1.1e-05	0.00247	CbGpPWpGaD
Megestrol acetate—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	1.06e-05	0.00238	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—GPR65—multiple sclerosis	1.05e-05	0.00234	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	1.05e-05	0.00234	CbGpPWpGaD
Megestrol acetate—NR3C1—Gene Expression—ZFP36L1—multiple sclerosis	1.04e-05	0.00233	CbGpPWpGaD
Megestrol acetate—PGR—Signaling by ERBB4—IL6—multiple sclerosis	1.04e-05	0.00233	CbGpPWpGaD
Megestrol acetate—NR3C1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	1.01e-05	0.00225	CbGpPWpGaD
Megestrol acetate—NR3C1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	9.86e-06	0.00221	CbGpPWpGaD
Megestrol acetate—NR3C1—Adipogenesis—STAT3—multiple sclerosis	9.77e-06	0.00218	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—CCR1—multiple sclerosis	9.57e-06	0.00214	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—CXCL13—multiple sclerosis	9.57e-06	0.00214	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	9.32e-06	0.00209	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—IL2—multiple sclerosis	9.29e-06	0.00208	CbGpPWpGaD
Megestrol acetate—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	9.19e-06	0.00206	CbGpPWpGaD
Megestrol acetate—NR3C1—Adipogenesis—TGFB1—multiple sclerosis	9.05e-06	0.00203	CbGpPWpGaD
Megestrol acetate—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	8.92e-06	0.002	CbGpPWpGaD
Megestrol acetate—NR3C1—Adipogenesis—TNF—multiple sclerosis	8.45e-06	0.00189	CbGpPWpGaD
Megestrol acetate—NR3C1—Generic Transcription Pathway—VDR—multiple sclerosis	8.34e-06	0.00186	CbGpPWpGaD
Megestrol acetate—NR3C1—Gene Expression—PABPC1—multiple sclerosis	8.09e-06	0.00181	CbGpPWpGaD
Megestrol acetate—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	7.86e-06	0.00176	CbGpPWpGaD
Megestrol acetate—NR3C1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	7.31e-06	0.00163	CbGpPWpGaD
Megestrol acetate—NR3C1—Gene Expression—RPL5—multiple sclerosis	7.3e-06	0.00163	CbGpPWpGaD
Megestrol acetate—ABCB1—Metabolism—SRM—multiple sclerosis	7.27e-06	0.00163	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	7.24e-06	0.00162	CbGpPWpGaD
Megestrol acetate—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.05e-06	0.00158	CbGpPWpGaD
Megestrol acetate—PGR—Gene Expression—VDR—multiple sclerosis	6.94e-06	0.00155	CbGpPWpGaD
Megestrol acetate—NR3C1—Adipogenesis—IL6—multiple sclerosis	6.82e-06	0.00153	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—CCL3—multiple sclerosis	6.82e-06	0.00152	CbGpPWpGaD
Megestrol acetate—ABCB1—Allograft Rejection—TNF—multiple sclerosis	6.76e-06	0.00151	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—PTGER4—multiple sclerosis	6.56e-06	0.00147	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—CXCR3—multiple sclerosis	6.34e-06	0.00142	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—CD28—multiple sclerosis	6.28e-06	0.0014	CbGpPWpGaD
Megestrol acetate—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.23e-06	0.00139	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—CCR2—multiple sclerosis	6.16e-06	0.00138	CbGpPWpGaD
Megestrol acetate—NR3C1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	5.9e-06	0.00132	CbGpPWpGaD
Megestrol acetate—NR3C1—Gene Expression—PGR—multiple sclerosis	5.74e-06	0.00128	CbGpPWpGaD
Megestrol acetate—PGR—Generic Transcription Pathway—MYC—multiple sclerosis	5.73e-06	0.00128	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—CNR1—multiple sclerosis	5.69e-06	0.00127	CbGpPWpGaD
Megestrol acetate—ABCB1—Metabolism—CYP27B1—multiple sclerosis	5.13e-06	0.00115	CbGpPWpGaD
Megestrol acetate—ABCB1—Metabolism—CYP24A1—multiple sclerosis	5.13e-06	0.00115	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—CXCL10—multiple sclerosis	5.12e-06	0.00115	CbGpPWpGaD
Megestrol acetate—ABCB1—Metabolism—GPC5—multiple sclerosis	4.69e-06	0.00105	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—CD86—multiple sclerosis	4.48e-06	0.001	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—CCL5—multiple sclerosis	4.41e-06	0.000986	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—SPP1—multiple sclerosis	4.08e-06	0.000913	CbGpPWpGaD
Megestrol acetate—NR3C1—Gene Expression—VDR—multiple sclerosis	4.01e-06	0.000898	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—CCR5—multiple sclerosis	3.97e-06	0.000889	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—IL2RA—multiple sclerosis	3.91e-06	0.000876	CbGpPWpGaD
Megestrol acetate—ABCB1—Metabolism—RRM1—multiple sclerosis	3.88e-06	0.000869	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—APOE—multiple sclerosis	3.61e-06	0.000808	CbGpPWpGaD
Megestrol acetate—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	3.58e-06	0.000802	CbGpPWpGaD
Megestrol acetate—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	3.58e-06	0.0008	CbGpPWpGaD
Megestrol acetate—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	3.51e-06	0.000784	CbGpPWpGaD
Megestrol acetate—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	3.34e-06	0.000747	CbGpPWpGaD
Megestrol acetate—NR3C1—Generic Transcription Pathway—MYC—multiple sclerosis	3.31e-06	0.000741	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—CD80—multiple sclerosis	3.27e-06	0.000731	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—POMC—multiple sclerosis	3.1e-06	0.000694	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—CCL2—multiple sclerosis	3.04e-06	0.000679	CbGpPWpGaD
Megestrol acetate—PGR—Gene Expression—MYC—multiple sclerosis	2.76e-06	0.000617	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—TYK2—multiple sclerosis	2.76e-06	0.000617	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—IL2—multiple sclerosis	2.3e-06	0.000513	CbGpPWpGaD
Megestrol acetate—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.24e-06	0.000502	CbGpPWpGaD
Megestrol acetate—ABCB1—Metabolism—BCHE—multiple sclerosis	2.23e-06	0.000499	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—MMP9—multiple sclerosis	2.17e-06	0.000486	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—STAT3—multiple sclerosis	1.93e-06	0.000432	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—MYC—multiple sclerosis	1.79e-06	0.000401	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—TGFB1—multiple sclerosis	1.79e-06	0.0004	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—MAPK1—multiple sclerosis	1.76e-06	0.000393	CbGpPWpGaD
Megestrol acetate—NR3C1—Gene Expression—MYC—multiple sclerosis	1.6e-06	0.000357	CbGpPWpGaD
Megestrol acetate—PGR—Signaling Pathways—IL6—multiple sclerosis	1.35e-06	0.000302	CbGpPWpGaD
Megestrol acetate—ABCB1—Metabolism—APOE—multiple sclerosis	1.34e-06	0.0003	CbGpPWpGaD
Megestrol acetate—ABCB1—Metabolism—POMC—multiple sclerosis	1.15e-06	0.000258	CbGpPWpGaD
Megestrol acetate—ABCB1—Metabolism—ALB—multiple sclerosis	1.05e-06	0.000235	CbGpPWpGaD
